Albert Yueh-Peng Hung

Albert Yueh-Peng Hung is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as Vice President of Business and Deputy Chief Operating Officer at Adimmune Corp since March 2016, where involvement in COVID-19 vaccine development and the management of various strategic projects has been pivotal. Previously, roles included Director of New Business Development at Animmune and President of Reber Genetics, focusing on innovative biologicals and swine-subunit vaccines across Asia and Russia. With extensive experience in business development, operational management, and team leadership, Albert's educational background includes a Master's Degree in Veterinary Preventive Medicine and a Bachelor's Degree in Veterinary Medicine from National Taiwan University.